Snow delays Amylin/Lilly's once-weekly Byetta
This article was originally published in Scrip
Executive Summary
Extreme weather has forced the US FDA to push back by one week the PDUFA date for Amylin/Lilly's once-weekly formulation of Byetta (exenatide), an injectable GLP-1 analogue for the treatment of type 2 diabetes. The drug's new PDUFA is March 12th.